送了外国导师一套茶具态度立马就变了 ...

2025年ESMO靶向抗癌治疗大会（ESMO TAT 2025）已于3月3日至5日在法国巴黎圆满落幕。会议围绕新型药物联合治疗、人工智能应用、细胞疗法等前沿议题展开讨论，展示了抗体药物偶联物、双特异性抗体及T细胞受体疗法等领域的重大突破，为肿瘤治疗的未来注入新动力。在会议现场，《肿瘤瞭望》特邀 大会联合主席、西班牙Vall d'Hebron肿瘤研究所（VHIO ）临床研究项目联合主任Elena ...

REVEAL GENOMICS ®, a pioneering Barcelona-based biotech company dedicated to advancing precision oncology, is proud to announce the publication of a groundbreaking study demonstrating the clinical ...

2025年3月3日至5日，位于法国巴黎的ESMO国际大会吸引了众多关注的目光。本次会议围绕新型药物联合治疗、人工智能应用、细胞疗法等多个前沿议题展开讨论，展示了抗体药物偶联物、双特异性抗体及T细胞受体疗法的最新研究成果，为肿瘤治疗的未来注入了全新的动力。

BARCELONA, Spain--(BUSINESS WIRE)--REVEAL GENOMICS ®, a pioneering Barcelona-based biotech company dedicated to advancing precision oncology, is proud to announce the publication of a groundbreaking ...

aDepartment of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milan, 20072, Italy bMedical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS ...

Personalis reported a narrower-than-expected loss for Q4 2024. Revenue decreased by 15% year-over-year to $16.8 million. The stock price dropped by 5.36% in after-hours trading. The company ...

Personalis reported a narrower-than-expected loss for Q4 2024. Revenue decreased by 15% year-over-year to $16.8 million. The stock price dropped by 5.36% in after-hours trading. The company continues ...